| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0741-8329(02)00228-8 |
| P698 | PubMed publication ID | 12163144 |
| P2093 | author name string | Isabel Pérez-Mato | |
| Fernando J Corrales | |||
| José M Mato | |||
| Elena R García-Trevijano | |||
| M Ujue Latasa | |||
| L A Martínez-Cruz | |||
| Manuel M del Pino | |||
| María L Martínez-Chantar | |||
| Matiías A Avila | |||
| P2860 | cites work | Cloning, expression, and functional characterization of the beta regulatory subunit of human methionine adenosyltransferase (MAT II) | Q22011144 |
| S-adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: a new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver | Q28575436 | ||
| Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver | Q28581508 | ||
| S-adenosylmethionine synthesis: molecular mechanisms and clinical implications | Q28646532 | ||
| Prevention and treatment of liver fibrosis based on pathogenesis | Q33661202 | ||
| Amino acid metabolism in liver disease | Q33715385 | ||
| Methionine metabolism in mammals | Q34366989 | ||
| Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease | Q34544061 | ||
| Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation | Q35885731 | ||
| Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease | Q37785034 | ||
| Labile methyl groups and the promotion of cancer | Q38164562 | ||
| Methionine adenosyltransferase: structure and function | Q40799580 | ||
| Liver-specific methionine adenosyltransferase MAT1A gene expression is associated with a specific pattern of promoter methylation and histone acetylation: implications for MAT1A silencing during transformation. | Q40907508 | ||
| Carnitine metabolism in chronic liver disease | Q41206490 | ||
| Cytochrome P-4502E1: its physiological and pathological role | Q41441345 | ||
| Inhibition of liver methionine adenosyltransferase gene expression by 3-methylcolanthrene: protective effect of S-adenosylmethionine. | Q43574315 | ||
| Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I. | Q43890234 | ||
| Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix | Q45078167 | ||
| Nitric oxide inactivates rat hepatic methionine adenosyltransferase In vivo by S-nitrosylation | Q45889385 | ||
| Changes in S-adenosylmethionine synthetase in human liver cancer: molecular characterization and significance | Q46135216 | ||
| Specific loss of the high-molecular-weight form of S-adenosyl-L-methionine synthetase in human liver cirrhosis | Q47176613 | ||
| Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products | Q48777148 | ||
| Defective methionine metabolism in cirrhosis: relation to severity of liver disease. | Q51605191 | ||
| S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. | Q55033177 | ||
| The effect of ethanol on one-carbon metabolism: Increased methionine catabolism and lipotrope methyl-group wastage | Q57677683 | ||
| Hepatic Phosphatidylethanolamine Methyltransferase Activity Is Decreased by Ethanol and Increased by Phosphatidylcholine | Q61785760 | ||
| Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma | Q62727088 | ||
| Labile methyl balances for normal humans on various dietary regimens | Q66925044 | ||
| S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury | Q67555817 | ||
| S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis | Q68257612 | ||
| Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study | Q68512879 | ||
| S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon | Q68716606 | ||
| Effects of prolonged ethanol feeding on methionine metabolism in rat liver | Q69015074 | ||
| The leaky gut of alcoholism: possible route of entry for toxic compounds | Q72571576 | ||
| In vivo regulation by glutathione of methionine adenosyltransferase S-nitrosylation in rat liver | Q73225054 | ||
| Polyenylphosphatidylcholine attenuates alcohol-induced fatty liver and hyperlipemia in rats | Q73648925 | ||
| Interaction of liver methionine adenosyltransferase with hydroxyl radical | Q73804234 | ||
| Decreased carnitine biosynthesis in rats with secondary biliary cirrhosis | Q73825689 | ||
| Hepatocyte growth factor induces MAT2A expression and histone acetylation in rat hepatocytes: role in liver regeneration | Q73853309 | ||
| Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes | Q74133491 | ||
| S-Adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes | Q77335023 | ||
| Role of S-adenosyl-L-methionine in the treatment of liver diseases | Q78001335 | ||
| Rate of Disappearance From Plasma of Intravenously Administered Methionine in Patients With Liver Damage | Q81148006 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 163-167 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | Alcohol | Q15724430 |
| P1476 | title | S-Adenosylmethionine revisited: its essential role in the regulation of liver function | |
| P478 | volume | 27 |
| Q40571158 | 5'-methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes. |
| Q42609070 | A S-adenosylmethionine synthetase gene from the pathogenic piscine hemoflagellate, Cryptobia salmositica |
| Q36752271 | Acidic sphingomyelinase downregulates the liver-specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor-induced lethal hepatitis |
| Q36016487 | Alcohol-induced S-adenosylhomocysteine accumulation in the liver sensitizes to TNF hepatotoxicity: possible involvement of mitochondrial S-adenosylmethionine transport |
| Q33419494 | Alterations in the glutathione metabolism could be implicated in the ischemia-induced small intestinal cell damage in horses |
| Q38971165 | Altered methylation of specific DNA loci in the liver of Bhmt-null mice results in repression of Iqgap2 and F2rl2 and is associated with development of preneoplastic foci |
| Q46937417 | Differential regulation of the JNK/AP-1 pathway by S-adenosylmethionine and methylthioadenosine in primary rat hepatocytes versus HuH7 hepatoma cells. |
| Q36661777 | Diverse metabolic model parameters generate similar methionine cycle dynamics |
| Q35308068 | Effects of excessive dietary methionine on oxidative stress and dyslipidemia in chronic ethanol-treated rats |
| Q33742463 | Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury |
| Q37424324 | Homocysteine and lipids: S-adenosyl methionine as a key intermediate |
| Q43290042 | In-silico gene essentiality analysis of polyamine biosynthesis reveals APRT as a potential target in cancer. |
| Q45885229 | Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis |
| Q34103693 | Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease |
| Q36316956 | Pathophysiological basis for antioxidant therapy in chronic liver disease |
| Q35206697 | Review article: Nutritional therapy in alcoholic liver disease |
| Q26746703 | The Impact of External Factors on the Epigenome: In Utero and over Lifetime |
| Q34554574 | The use of selected nutrition supplements and complementary and alternative medicine in liver disease |
| Q47146711 | Tumor-suppressive effect of S-adenosylmethionine supplementation in a murine model of inflammation-mediated hepatocarcinogenesis is dependent on treatment longevity |
Search more.